LAROTRECTINIB

301 reported adverse events

Drug classes: Kinase Inhibitor [EPC]

These side effects are most commonly reported by patients taking LAROTRECTINIB:

# Side effect Count
0 DIZZINESS 23
1 FATIGUE 23
2 NAUSEA 18
3 DRUG INEFFECTIVE 17
4 PAIN 16
5 DISEASE PROGRESSION 15
6 OFF LABEL USE 15
7 PARAESTHESIA 11
8 DEATH 10
9 VOMITING 10
See all common reactions for LAROTRECTINIB

LAROTRECTINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NTRK GENE FUSION OVEREXPRESSION 1 0.5000
1 NASAL ASPIRATION 1 0.2500
2 FIBROSARCOMA METASTATIC 1 0.2000
3 UPPER AIRWAY NECROSIS 1 0.1250
4 SALIVARY GLAND CANCER RECURRENT 1 0.1111
5 NEUROENDOCRINE CARCINOMA OF PROSTATE 1 0.0909
6 DESMOPLASTIC SMALL ROUND CELL TUMOUR 2 0.0370
7 NEUROENDOCRINE TUMOUR OF THE LUNG METASTATIC 1 0.0345
8 NERVOUS SYSTEM NEOPLASM 1 0.0250
9 MENINGIOMA MALIGNANT 1 0.0238
See all enriched reactions for LAROTRECTINIB